TransCode Therapeutics Inc. (RNAZ) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for TransCode Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.74
+4.19% today
Market cap
$28M
Overall quality
—
Kronos AI 30-day
+110.0%
7 of 8 simulated paths end higher
TransCode Therapeutics Inc. (RNAZ) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $28M. It trades at $1.74, up 4.19% today. Kronos AI's 30-day forecast is +110.0% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $3.51 (+110.0%) |
| Likely range | +54.6% … +192.3% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.